The most common any-grade AEs for patients with hormone receptor-positive BC who received hormonal therapy were diarrhea (n = 83 [64.8%]), alopecia (n = 59 [46.1%]), and asthenia (n = 48 [37.5%]). Here, NR4A1 is linked to alopecia.